|
|
| Quarterly Results |
|
| Alpa Laboratories Ltd | | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Mahendra Singh Chawla | | Home : Indian Private | Book Value: 72.8658745 | | BSE Code : 532878 | Market Cap: 200.32 | | NSE Code : ALPA | P / E : 11.2 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 27.31 | 32.39 | 25.43 | 29.16 | | Other Income | 3.55 | 2.95 | 4.47 | -0.76 | | Total Income | 30.86 | 35.35 | 29.90 | 28.40 | | Total Expenditure | 24.85 | 29.08 | 26.58 | 19.90 | | Operating Profit | 6.01 | 6.27 | 3.32 | 8.50 | | Interest | 0.03 | 0.04 | 0.02 | 0.04 | | Gross Profit | 5.98 | 6.23 | 3.30 | 8.46 | | Depreciation | 0.66 | 0.49 | 0.28 | 0.53 | | Tax | 0.00 | 0.00 | 0.00 | 3.60 | | Deferred Tax | 0.79 | 0.00 | 0.00 | -0.29 | | Reported Profit After Tax | 4.53 | 5.74 | 3.03 | 4.62 |
|
|
|
|
|